MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL

Qiang Lu1, Chao Lu, Guo-Ping Zhou

  • 1Department of Urology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Urologic Oncology
|September 22, 2009
PubMed
Abstract

Insights

Silencing microRNA-221 (miRNA-221) in bladder cancer cells increases their susceptibility to TRAIL-induced apoptosis. This suggests miRNA-221 suppression is a potential therapeutic strategy for bladder cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Bladder cancer presents a significant therapeutic challenge, particularly in advanced stages, with limited survival rates.
  • MicroRNAs (miRNAs) are emerging as key regulators in cancer development, with specific miRNAs implicated in various malignancies.
  • miRNA-221 has been identified as potentially oncogenic, warranting investigation into its role in bladder cancer.

Purpose of the Study:

  • To investigate the therapeutic potential of silencing miRNA-221 in bladder cancer.
  • To determine the effect of miRNA-221 suppression on the chemosensitivity of bladder cancer cells to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand).

Main Methods:

  • Northern blot analysis was employed to quantify miRNA-221 expression in bladder cancer cell lines (T24, RT4) and normal urothelial cells.
  • Antisense oligonucleotides were used to silence miRNA-221 in T24 cells.
  • Flow cytometry assessed apoptosis induction by TRAIL in miRNA-221-silenced cells and analyzed cell cycle distribution.
  • Western blotting detected p27(kip1) protein levels in response to TRAIL treatment in silenced cells.

Main Results:

  • miRNA-221 was significantly upregulated in bladder cancer cells (T24, RT4) compared to normal urothelial cells.
  • Silencing miRNA-221 sensitized TRAIL-resistant T24 bladder cancer cells to TRAIL-induced apoptosis.
  • miRNA-221 suppression led to increased p27(kip1) protein levels and enhanced caspase-3 activation upon TRAIL treatment.

Conclusions:

  • Silencing miRNA-221 enhances TRAIL-induced apoptosis in human bladder cancer T24 cells.
  • These findings highlight the potential of miRNA-221 suppression as a novel therapeutic approach for bladder cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...